CrossRef
Works that cite this article, indexed by Crossref.
Mixed probiotics reduce the severity of stress-induced depressive-like behaviors
Journal of Affective Disorders 355 (2024)
Xianguo Li; Xukai Cheng; Yongping Shi; Chenxing Jian; Wenzhong Zhu; Haijun Bao; Mi Jiang; Zuojie Peng; Yuan Hu; Jinhuang Chen; Xiaogang Shu
Mirogabalin prevents repeated restraint stress-induced dysfunction in mice
Behavioural Brain Research 383 (2020)
Takashi Iwai; Akinori Kikuchi; Misa Oyama; Shun Watanabe; Mitsuo Tanabe
An overview of 5-HT3 receptor antagonists as a treatment option for irritable bowel syndrome with diarrhea
Expert Opinion on Pharmacotherapy 24(10) (2023)
Karolina Merecz; Mikołaj Hirsa; Olga Biniszewska; Jakub Fichna; Aleksandra Tarasiuk
Shaoyao‐Gancao Decoction Relieves Visceral Hyperalgesia in TNBS‐Induced Postinflammatory Irritable Bowel Syndrome via Inactivating Transient Receptor Potential Vanilloid Type 1 and Reducing Serotonin Synthesis
Evidence-Based Complementary and Alternative Medicine 2020(1) (2020)
Yun-Yun Shao; Yi-Ting Guo; Jian-ping Gao; Jun-Jin Liu; Zhuang-Peng Chang; Xiao-Juan Feng; Ding Xu; Gui-Feng Deng; Rui-Gang Hou; XiuMin Li
Depression and Pain: Use of Antidepressants
Current Neuropharmacology 20(2) (2022)
Herlinda Bonilla-Jaime; José Armando Sánchez-Salcedo; M. Maetzi Estevez-Cabrera; Tania Molina-Jiménez; José Luis Cortes-Altamirano; Alfonso Alfaro-Rodríguez
Pharmacological approaches to treat intestinal pain
Expert Review of Clinical Pharmacology 16(4) (2023)
Mikolaj Swierczynski; Adam Makaro; Agata Grochowska; Maciej Salaga
Long‐lasting visceral hypersensitivity in a model of DSS‐induced colitis in rats
Neurogastroenterology & Motility 34(11) (2022)
Sergio López‐Estévez; Josep Manuel López‐Torrellardona; Marc Parera; Vicente Martínez
Essential role of Cav3.2 T-type calcium channels in butyrate-induced colonic pain and nociceptor hypersensitivity in mice
European Journal of Pharmacology 887 (2020)
Maho Tsubota; Kazuki Matsui; Maki Nakano; Rie Kajitani; Yuko Ishii; Ken Tomochika; Yuta Nishikawa; Saaya Fukushi; Ayumu Yamagata; Fumiko Sekiguchi; Takuya Okada; Naoki Toyooka; Atsufumi Kawabata
Therapeutic effects of saffron (Crocus sativus) versus fluoxetine on Irritable Bowel Syndrome: A double-blind randomized clinical trial
Advances in Integrative Medicine 6(4) (2019)
Borna Tadyon Najafabadi; Kiandokht Ghamari; Tahereh Kermany Ranjabari; Ahmad Ali Noorbala; Naser Ebrahimi Daryani; Elmira Vanaki; Shahin Akhondzadeh
Evaluation and Management Strategies for GI Involvement with Amyloidosis
The American Journal of Medicine 135 (2022)
Cassandra D.L. Fritz; Elizabeth Blaney
Suppression of visceral nociception by C-fiber transmission block using temporal interference sinusoidal stimulation
PAIN Reports 11(4) (2026)
Longtu Chen; Shaopeng Zhang; Eric Woon; Jia Liu; Jaehyeon Ryu; Hsin Chen; Guoan Zheng; Hui Fang; Bin Feng
Monocyte/High-Density Lipoprotein Ratio as an Inflammatory Marker in Patients with Irritable Bowel Syndrome
Medical Science and Discovery 10(10) (2023)
Çağdaş Erdoğan; İbrahim Ethem Güven; Batuhan Başpınar; Zeki Mesut Yalın Kılıç
Blocking peripheral drive from colorectal afferents by subkilohertz dorsal root ganglion stimulation
Pain 163(4) (2022)
Longtu Chen; Tiantian Guo; Shaopeng Zhang; Phillip P. Smith; Bin Feng
Improving the Treatment Response of Patients with Irritable Bowel Syndrome: Implementing a Second-Generation Artificial Intelligence System for Overcoming Resistance
GastroHep 2022 (2022)
Anat Hershko-Moshe; Yaako’v Hasin; Anat Nevo-Shor; Ohad Etzion; Yaron Ilan; Soe Thiha Maung
Potential neuro-immune therapeutic targets in irritable bowel syndrome
Therapeutic Advances in Gastroenterology 13 (2020)
Maite Casado-Bedmar; Åsa V. Keita
Effect of Samryungbaekchul-san Combined with Otilonium Bromide on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial
Journal of Clinical Medicine 8(10) (2019)
Jin-Hyun Lee; Joong Il Kim; Myong Ki Baeg; Yun-Young Sunwoo; Kwangsun Do; Jung-Han Lee; Hye-Jung Kim; Ja Sung Choi; Jayoung Kim; Chang-Seob Seo; Hyeun-Kyoo Shin; Hyekyung Ha; Tae-Yong Park
Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
Journal of Gastroenterology 56(3) (2021)
Shin Fukudo; Toshikatsu Okumura; Masahiko Inamori; Yusuke Okuyama; Motoyori Kanazawa; Takeshi Kamiya; Ken Sato; Akiko Shiotani; Yuji Naito; Yoshiko Fujikawa; Ryota Hokari; Tastuhiro Masaoka; Kazuma Fujimoto; Hiroshi Kaneko; Akira Torii; Kei Matsueda; Hiroto Miwa; Nobuyuki Enomoto; Tooru Shimosegawa; Kazuhiko Koike
Comparisons of different electrical stimulation modalities for treating visceral pain in a rodent model of irritable bowel syndrome
Bioelectronic Medicine 10(1) (2024)
Md Jahangir Alam; Tingting Zhao; John W. Wiley; Jiande D. Z. Chen
Endocannabinoid system modulation for visceral abdominal pain in inflammatory bowel disease and irritable bowel syndrome: A protocol for systematic review and meta-analysis
HRB Open Research 8 (2025)
Rebecca M. Lane; Laurence J. Egan; Brian E. McGuire; Declan P. McKernan; Siobhain M. O'Mahony; David P. Finn
Effects of Electroacupuncture at ST36 on Visceral Pain and Inflammatory Markers in IBS Rats
Neurogastroenterology & Motility 38(5) (2026)
Ya‐bo Hao; Yan‐lin Liu; Xiao‐mei Wang; Kai Cheng; Qing‐yu Tu; Fei Dai; Xi‐bing Yang
Somatosensory Profiles Differentiate Pain and Psychophysiological Symptoms Among Young Adults With Irritable Bowel Syndrome
The Clinical Journal of Pain 38(7) (2022)
Jie Chen; Yiming Zhang; Zahra A. Barandouzi; Wanli Xu; Bin Feng; Ki Chon; Melissa Santos; Angela Starkweather; Xiaomei Cong
Endocannabinoid system modulation for visceral abdominal pain in inflammatory bowel disease and irritable bowel syndrome: A protocol for systematic review and meta-analysis
HRB Open Research 8 (2025)
Rebecca M. Lane; Laurence J. Egan; Brian E. McGuire; Declan P. McKernan; Siobhain M. O'Mahony; David P. Finn
Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review
Archiv der Pharmazie 357(10) (2024)
Aylin Deljavan Ghodrati; Tansel Comoglu
Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review
Neurology International 13(3) (2021)
Amber N. Edinoff; Haseeb A. Akuly; Tony A. Hanna; Carolina O. Ochoa; Shelby J. Patti; Yahya A. Ghaffar; Alan D. Kaye; Omar Viswanath; Ivan Urits; Andrea G. Boyer; Elyse M. Cornett; Adam M. Kaye
Risk of psychiatric disorders in irritable bowel syndrome-A nationwide, population-based, cohort study
International Journal of Clinical Practice 72(7) (2018)
Hui-Wen Yeh; Wu-Chien Chien; Chi-Hsiang Chung; Je-Ming Hu; Nian-Sheng Tzeng
Editorial: Emerging trends in abdominal and pelvic pain
Frontiers in Pain Research 4 (2023)
Bin Feng; Anna P. Malykhina
The Associations of Single Nucleotide Polymorphisms with Risk and Symptoms of Irritable Bowel Syndrome
Journal of Personalized Medicine 12(2) (2022)
Tingting Zhao; Yiming Zhang; Joochul Lee; Angela R. Starkweather; Erin E. Young; Xiaomei Cong
Pain Severity Correlates With Biopsy-Mediated Colonic Afferent Activation But Not Psychological Scores in Patients With IBS-D
Clinical and Translational Gastroenterology 12(2) (2021)
Vincent Cibert-Goton; Ching Lam; Melanie Lingaya; Yirga Falcone; John N. Wood; David C. Bulmer; Robin Spiller
Painful neurotrophins and their role in visceral pain
Behavioural Pharmacology 29(2 and 3) (2018)
Ana E. López-Pérez; Kulmira Nurgali; Raquel Abalo
Optical recording reveals topological distribution of functionally classified colorectal afferent neurons in intact lumbosacral DRG
Physiological Reports 7(9) (2019)
Tiantian Guo; Zichao Bian; Kyle Trocki; Longtu Chen; Guoan Zheng; Bin Feng
Fecal microbiota transplantation ameliorates gut microbiota imbalance and intestinal barrier damage in rats with stress‐induced depressive‐like behavior
European Journal of Neuroscience 53(11) (2021)
Jingjing Rao; Ruining Xie; Li Lin; Jian Jiang; Lei Du; Xindie Zeng; Gongying Li; Chunmei Wang; Yi Qiao; Camilla Bellone
Systematic Review on Herbal Preparations for Controlling Visceral Hypersensitivity in Functional Gastrointestinal Disorders
Current Pharmaceutical Biotechnology 25(13) (2024)
Naser-Aldin Lashgari; Nazanin Momeni Roudsari; Saeideh Momtaz; Faezeh Niazi Shahraki; Nadia Zandi; Benyamin Pazoki; Mohammad Hosein Farzaei; Mehdi Ghasemi; Mohammad Abdollahi; Amir Hossein Abdolghaffari
Oxytocin Verbindungen zur oralen Behandlung von Bauchschmerzen
Angewandte Chemie 136(52) (2024)
Thomas Kremsmayr; Gudrun Schober; Matthias Kaltenböck; Bradley L. Hoare; Stuart M. Brierley; Markus Muttenthaler
Using the Rome IV Criteria to Help Manage the Complex IBS Patient
American Journal of Gastroenterology 113(4) (2018)
Lisa D Lin; Lin Chang
High-Throughput Functional Characterization of Visceral Afferents by Optical Recordings From Thoracolumbar and Lumbosacral Dorsal Root Ganglia
Frontiers in Neuroscience 15 (2021)
Zichao Bian; Tiantian Guo; Shaowei Jiang; Longtu Chen; Jia Liu; Guoan Zheng; Bin Feng
Limited Utility for Benzodiazepines in Chronic Pain Management: A Narrative Review
Advances in Therapy 37(6) (2020)
Steven L. Wright
Belgian consensus on irritable bowel syndrome
Acta Gastro Enterologica Belgica 85(2) (2022)
S Kindt; H Louis; H De Schepper; J Arts; P Caenepeel; D De Looze; A Gerkens; T Holvoet; P Latour; T Mahler; F Mokaddem; S Nullens; H Piessevaux; P Poortmans; G Rasschaert; M Surmont; H Vafa; K Van Malderen; T Vanuytsel; F Wuestenberghs; J Tack
Why Use Nutraceutical Strategies for the Irritable Bowel Syndrome?
Current Medicinal Chemistry 29(12) (2022)
Flavia di Michele
Antispasmodic Effect of Bergamot Essential Oil on Rat Isolated Gut Tissues
Pharmaceutics 14(4) (2022)
Laura Rombolà; Marilisa Straface; Damiana Scuteri; Tsukasa Sakurada; Shinobu Sakurada; Maria Tiziana Corasaniti; Giacinto Bagetta; Luigi Antonio Morrone
Complex visceral hyperalgesia in an adolescent with Pitt-Hopkins syndrome
BMJ Case Reports 17(2) (2024)
Laura Reaney; Aedin Collins
Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study
PLOS ONE 14(8) (2019)
Yung-Chu Hsu; Hsin-Yi Yang; Wan-Ting Huang; Solomon Chih-Cheng Chen; Herng-Sheng Lee; Rachel A. Annunziato
Pain management in a patient with intestinal failure in the palliative care setting: case report
BMC Palliative Care 24(1) (2025)
Adarsh Das; Jayamangala Sampath Kondasinghe
Duloxetine as a gut-brain axis modulator in irritable bowel syndrome: neuroimmune, microbiota, and pharmacogenomic perspectives
Naunyn-Schmiedeberg's Archives of Pharmacology 399(11) (2026)
Mokhtar Rejili; Aya M. Mustafa; Hayder M. Al-kuraishy; Nawar R. Hussein; Thabat J. Al-Maiahy; Ali I. Al-Gareeb; Ali K. Albuhadily; Gaber El-Saber Batiha
Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo‐controlled trial (CAPTIVATE)
Neurogastroenterology & Motility 35(5) (2023)
Lin Chang; Brooks D. Cash; Anthony Lembo; David C. Kunkel; Brett A. English; Beatriz Lindstrom; Guibao Gu; Sharon Skare; Kye Gilder; Stewart Turner; Fabio Cataldi; Donald Lipkis; Jan Tack
Oxytocin Analogues for the Oral Treatment of Abdominal Pain
Angewandte Chemie International Edition 63(52) (2024)
Thomas Kremsmayr; Gudrun Schober; Matthias Kaltenböck; Bradley L. Hoare; Stuart M. Brierley; Markus Muttenthaler
Improvement in constipation and diarrhea is associated with improved abdominal pain in patients with functional bowel disorders
Neurogastroenterology & Motility 34(4) (2022)
Vikram Rangan; Prashant Singh; Sarah Ballou; Rafla Hassan; Vanessa Yu; Jesse Katon; Judy Nee; Johanna Iturrino; Anthony Lembo
New Insights on Expression and Function of Mu and Delta Opioid Receptors in Mouse Gastrointestinal Tract
Cellular and Molecular Gastroenterology and Hepatology 9(3) (2020)
Bin Feng
Blocking Aδ- and C-fiber neural transmission by sub-kilohertz peripheral nerve stimulation
Frontiers in Neuroscience 18 (2024)
Shaopeng Zhang; Longtu Chen; Sajjad Rigi Ladez; Ahmet Seferge; Jia Liu; Bin Feng
Evaluation of the mechanism of action of paracetamol, drotaverine, and peppermint oil and their effects in combination with hyoscine butylbromide on colonic motility: human ex-vivo study
Frontiers in Pharmacology 15 (2024)
Sara Traserra; Claudia Barber; Luis Gerardo Alcalá-González; Stefania Landolfi; Robert Lange; Carolina Malagelada; Maura Corsetti; Marcel Jimenez
In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal
International Journal of Molecular Sciences 21(23) (2020)
Annalisa Maruca; Antonio Lupia; Roberta Rocca; Daniel Keszthelyi; Maura Corsetti; Stefano Alcaro
Review article: current and future treatment approaches for pain in IBS
Alimentary Pharmacology & Therapeutics 54(S1) (2021)
Peter Paine
The effect of eye movement desensitization and reprocessing (EMDR) on abdominal pain in patients with irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial (EMDR4IBS)
Trials 24(1) (2023)
B. Wertheim; E. E. Aarts; C. de Roos; Y. R. van Rood
Optimizing Pain Management in Palliative Care for a Patient with Intestinal Failure: A Case Report
Journal of Integrative Nursing and Palliative Care 5(1) (2024)
Hanadi Suhail; Edina Bihari; Edina Lempel
5-HT3receptor signaling in serotonin transporter-knockout rats: a female sex-specific animal model of visceral hypersensitivity
American Journal of Physiology-Gastrointestinal and Liver Physiology 316(1) (2019)
Nadine El-Ayache; James J. Galligan
Alterations of colonic sensitivity and gastric dysmotility after acute cisplatin and granisetron
Neurogastroenterology & Motility 31(3) (2019)
Marta Martín‐Ruíz; José A. Uranga; Paula Mosinska; Jakub Fichna; Kulmira Nurgali; Mª Isabel Martín‐Fontelles; Raquel Abalo
A Multimodal Intervention Using Nonopioid Analgesics Is Associated With Reduced Intravenous Opioid Exposure Among Hospitalized Patients With Inflammatory Bowel Diseases
American Journal of Gastroenterology 115(9) (2020)
Rahul S. Dalal; Sonali Palchaudhuri; Christopher K. Snider; Yevgeniy Gitelman; Mihir Brahmbhatt; Nikhil K. Mull; Shivan J. Mehta; Christopher Klock; James D. Lewis; Gary R. Lichtenstein
Chlorogenic acid improves intestinal barrier function by downregulating CD14 to inhibit the NF-κB signaling pathway
Journal of Functional Foods 85 (2021)
Lei-Min Yu; Li-Qi Mao; Chun-Yan Wu; Wei Ye; Xi Wang
How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel Syndrome
Cureus (2020)
Ilmaben S Vahora; Nicholas Tsouklidis; Rajat Kumar; Ravi Soni; Safeera Khan
NUCB2/Nesfatin-1 Regulation of Chronic Visceral Hyperalgesia
Applied Bionics and Biomechanics 2022 (2022)
Qiaoyan Gu; Yuan Lei; Jianming Wu; Ting He; Juanjuan Li; Shanshan Song; Fahd Abd Algalil
Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
Pediatric Drugs 25(1) (2023)
Rodrigo Vázquez-Frias; Alejandra Consuelo-Sánchez; Carlos Patricio Acosta-Rodríguez-Bueno; Andrés Blanco-Montero; Daniel Casas Robles; Vanessa Cohen; Daniel Márquez; Marcos Perez
Effects of Duloxetine on Gastrointestinal Symptoms, Depression, Anxiety, Stress, and Quality of Life in Patients with the Moderate-to-Severe Irritable Bowel Syndrome
Advanced Biomedical Research 12 (2023)
Mohammad Reza Sharbafchi; Hamid Afshar Zanjani; Zahra Saneian; Awat Feizi; Hamed Daghaghzadeh; Peyman Adibi
Trimebutine: a state-of-the-art review
Minerva Gastroenterologica e Dietologica 65(3) (2019)
Beatrice Salvioli
Can Sertraline and Nortriptyline Protect the Neurons in Submucosal and Myenteric Plexuses of Rat’s Colon Against Stress?
Digestive Diseases and Sciences 64(9) (2019)
Ali Noorafshan; Majid Yousefi; Leila Hosseini; Saied Karbalay-Doust